Briefing
KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic Model
In the NCT03575611 oligometastatic ccRCC cohort, baseline and 3-month plasma KIM-1 and ctDNA MRD status were each independently associated with systemic therapy-free survival, and a Weibull model combining baseline KIM-1, baseline ctDNA, and four clinical variables (K-COMPASS) had a C-index of 0.76.
- Design: Evidence level 2
- Assay: Not named in the abstract